RUSH UNIVERSITY MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1837-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.rush.edu/
Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer
- First Posted Date
- 2008-01-18
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 11
- Registration Number
- NCT00597597
- Locations
- 🇺🇸
Rush University Medical Center Division of Hematology/Oncology, Chicago, Illinois, United States
Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints
Not Applicable
Completed
- Conditions
- Subjective Memory Loss in Older Persons
- Interventions
- Other: Cerefolin NAC (a medical food)Other: Cerefolin NAC placebo
- First Posted Date
- 2008-01-18
- Last Posted Date
- 2013-05-23
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 104
- Registration Number
- NCT00597376
- Locations
- 🇺🇸
Rush Alzheimer's Disease Center, Chicago, Illinois, United States
Study Comparing Mini-Incision Versus 2-Incision Approach for Total Hip Replacement
Not Applicable
Completed
- Conditions
- Osteoarthritis
- Interventions
- Procedure: Mini Incision ApproachProcedure: 2 Incision Approach
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2012-08-31
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 72
- Registration Number
- NCT00594893
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.
Phase 4
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 176
- Registration Number
- NCT00591227
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
Safety of Driving After Minor Surgery with Monitored Anesthesia Care
Phase 4
Active, not recruiting
- Conditions
- Minor Surgical Procedures with Monitored Anesthesia CareDriving Performance After Minor Ambulatory Surgery
- Interventions
- First Posted Date
- 2007-12-20
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 625
- Registration Number
- NCT00577200
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
Mind/Body Medicine and IBD Flare-Up
Phase 1
Completed
- Conditions
- Ulcerative Colitis
- Interventions
- Behavioral: Mind/Body Courses
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2012-02-27
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 55
- Registration Number
- NCT00568256
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
Validation of Driving Simulator to Blood Alcohol Concentration Standards for Impaired Driving
Phase 3
Completed
- Conditions
- IntoxicationImpairmentAlcohol Impaired DrivingDriving
- Interventions
- Drug: placebo
- First Posted Date
- 2007-11-16
- Last Posted Date
- 2022-12-14
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT00559819
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
Prospective, Randomized Controlled Trial on Perioperative Pregabalin to Reduce Late-onset CRPS After TKA
- First Posted Date
- 2007-11-15
- Last Posted Date
- 2016-05-26
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 240
- Registration Number
- NCT00558753
Improve Speech Using an In-the-ear Device in Parkinson's Disease
Phase 1
Completed
- Conditions
- Parkinson's DiseaseDysarthria
- Interventions
- Device: SpeechEasy Model ITC
- First Posted Date
- 2007-06-20
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00488657
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
- First Posted Date
- 2007-05-28
- Last Posted Date
- 2021-11-04
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 1
- Registration Number
- NCT00479167
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath